Alpha 1 antichymotrypsin is aberrantly expressed during melanoma progression and predicts poor survival for patients with metastatic melanoma

Pigment Cell and Melanoma Research

Volumn 23, Issue 4, 2010, Pages 575-586

  Wang, Yang ^a   Jiang, Helen ^a   Dai, Derek ^a   Su, Mingwan ^a,b   Martinka, Magdalene ^c   Brasher, Penny ^b   Zhang, Yaohua ^a   McLean, David ^a   Zhang, Junling ^a   Ip, Wency ^a   Li, Gang ^a   Zhang, Xuejun ^d   Zhou, Youwen ^a,b,d,e  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b VANCOUVER COASTAL HEALTH RESEARCH INSTITUTE   (Canada)

^c VANCOUVER GENERAL HOSPITAL   (Canada)

^d ANHUI MEDICAL UNIVERSITY   (China)

^e BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; LACTATE DEHYDROGENASE;

CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CYTOPLASM; DISTANT METASTASIS; DNA BINDING; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; LYMPH NODE METASTASIS; MELANOMA; MITOSIS INDEX; NONHUMAN; PROGNOSIS; PROTEIN EXPRESSION; SKIN BIOPSY; TISSUE MICROARRAY; TUMOR XENOGRAFT; WESTERN BLOTTING;

EID: 77954742826     PISSN: 17551471     EISSN: 1755148X     Source Type: Journal    
DOI: 10.1111/j.1755-148X.2010.00715.x     Document Type: Letter

References (12)

1. Balch, C.M., Gershenwald, J.E., Soong, S.J. et al. (2009). Final version of 2009 AJCC melanoma staging and classification. J. Clin. Oncol. 27, 6199 6206.
2. Baumann, U., Huber, R., Bode, W., Grosse, D., Lesjak, M. Laurell, C.B. (1991). Crystal structure of cleaved human alpha 1-antichymotrypsin at 2.7 A resolution and its comparison with other serpins. J. Mol. Biol. 218, 595 606.
3. Bosserhoff, A.K. (2005). Melanoma inhibitory activity (MIA): an important molecule in melanoma development and progression. Pigment Cell Res. 18, 411 416.
4. Gould Rothberg, B.E., Bracken, M.B. Rimm, D.L. (2009). Tissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis. J. Natl. Cancer Inst. 101, 452 474.
5. Homsi, J., Kashani-Sabet, M., Messina, J.L. Daud, A. (2005). Cutaneous melanoma: prognostic factors. Cancer Control 12, 223 229.
6. Kondo, Y. Ohsawa, N. (1982). Production of human alpha 1-antichymotrypsin-like protein by a human malignant melanoma transplanted into nude mice. Cancer Res. 42, 1549 1554.
7. Naidoo, N., Cooperman, B.S., Wang, Z.M., Liu, X.Z. Rubin, H. (1995). Identification of lysines within alpha 1-antichymotrypsin important for DNA binding. An unusual combination of DNA-binding elements. J. Biol. Chem. 270, 14548 14555.
8. Nikkola, J., Vihinen, P., Vlaykova, T., Hahka-Kemppinen, M., Heino, J. Pyrhonen, S. (2004). Integrin chains beta1 and alphav as prognostic factors in human metastatic melanoma. Melanoma Res. 14, 29 37.
9. Nikkola, J., Vihinen, P., Vuoristo, M.S., Kellokumpu-Lehtinen, P., Kahari, V.M. Pyrhonen, S. (2005). High serum levels of matrix metalloproteinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma. Clin. Cancer Res. 11, 5158 5166.
10. Tang, L., Dai, D.L., Su, M., Martinka, M., Li, G. Zhou, Y. (2006). Aberrant expression of collagen triple helix repeat containing 1 in human solid cancers. Clin. Cancer Res. 12, 3716 3722.
11. Tarhini, A.A., Stuckert, J., Lee, S., Sander, C. Kirkwood, J.M. (2009). Prognostic significance of serum S100B protein in high-risk surgically resected melanoma patients participating in Intergroup Trial ECOG 1694. J. Clin. Oncol. 27, 38 44.
12. Zhou, Y., Dai, D.L., Martinka, M. et al. (2005). Osteopontin expression correlates with melanoma invasion. J. Invest. Dermatol. 124, 1044 1052.